AnaptysBio, Inc. ANAB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.56M-8.0% | $108.25M+151% | $76.32M+154% | $22.26M+103% | $27.77M+287% | ||
| $33.99M-17.5% | $25.56M-40.0% | $31.41M-25.6% | $37.82M-9.9% | $41.18M+11.2% | ||
| $26.2M+85.4% | $15.79M+54.9% | $10.21M-3.3% | $10.61M+14.1% | $14.13M+14.5% | ||
| $60.19M+8.8% | $41.35M-21.7% | $41.62M-21.1% | $48.43M-5.6% | $55.31M+12.0% | ||
| $60.19M+8.8% | $41.35M-21.7% | $41.62M-21.1% | $48.43M-5.6% | $55.31M+12.0% | ||
| -$34.64M-25.8% | $66.9M+792% | $34.7M+252% | -$26.17M+35.1% | -$27.54M+34.7% | ||
| -135.5%-36.4pp | 61.8%+84.2pp | 45.5%+121pp | -117.5%+250pp | -99.2%+489pp | ||
| $2.65M-39.9% | $2.51M-52.3% | $2.92M-45.1% | $3.65M-21.0% | $4.41M-3.7% | ||
| -$18.21M-55.0% | -$17.21M-42.0% | -$19.59M-94.1% | -$12.42M-96.2% | -$11.75M-577% | ||
| -$52.84M-34.5% | —— | $15.11M+146% | -$38.59M+17.3% | -$39.29M+10.6% | ||
| $40K-9.1% | $81K— | $0— | $39K+333% | $44K— | ||
| -$52.88M-34.5% | —— | $15.11M+146% | -$38.63M+17.2% | -$39.33M+10.5% | ||
| -206.9%-65.3pp | —— | 19.8%+129pp | -173.5%+252pp | -141.6%+470pp | ||
| -$1.84-43.8% | —— | $0.52+146% | -$1.34+21.6% | -$1.28+22.0% | ||
| -$1.84-43.8% | —— | $0.54+147% | -$1.34+21.6% | -$1.28+22.0% | ||
| 28.7M-6.4% | 28.8M+1.3% | 29M+0.4% | 28.8M+5.3% | 30.6M+14.3% | ||
| 28.7M-6.4% | 28.8M+1.3% | 27.8M-3.7% | 28.8M+5.3% | 30.6M+14.3% | ||
| $20.86M+15.5% | $19.71M+13.3% | $22.52M+46.1% | $19.61M+79.0% | $18.06M+186% | ||
| -$53.01M-34.3% | —— | $15.17M+148% | -$38.8M+16.5% | -$39.47M+9.8% | ||
| $2.65M-39.9% | $2.51M-52.3% | $2.92M-45.1% | $3.65M-21.0% | $4.41M-3.7% | ||
| -$122K+15.3% | -$71K— | $53K-95.5% | -$167K-180% | -$144K-183% | ||
| -$1K-100% | $0-100% | $0+100% | $3.53M— | $1.9M+95,200% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $33.99M-17.5% | —— | —— | —— | $41.18M+0.5% | ||
| $25.56M-8.0% | $108.25M+151% | $76.32M+154% | $22.26M+103% | $27.77M+287% | ||
| -$34.64M-25.8% | $66.9M+792% | $34.7M+252% | -$26.17M+35.1% | -$27.54M+34.7% | ||
| -$34.51M-26.0% | $67.03M+804% | $34.84M+254% | -$26.03M+35.2% | -$27.39M+34.8% | ||
| -$34.51M-26.0% | $67.03M+804% | $34.84M+254% | -$26.03M+35.2% | -$27.39M+34.8% | ||
| -135%-36.4pp | 61.9%+84.0pp | 45.7%+121pp | -116.9%+249pp | -98.6%+487pp | ||
| -$34.64M-25.8% | $66.9M+792% | $34.7M+252% | -$26.17M+35.1% | -$27.54M+34.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AnaptysBio, Inc.'s income statement data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.